Viking Therapeutics (VKTX) Stock News: October 2026

$VKTX · 2 stories in October 2026

October 2026

newest first · direct subject stories only

CorporateOct 6 · 7:05 AM ET

Viking Therapeutics initiates VK2735 oral maintenance dosing trial in obesity

Viking Therapeutics announced the start of a clinical trial evaluating oral maintenance dosing of VK2735 in patients with obesity. The study is designed to assess the drug's effect on weight maintenance after initial weight loss.

neutral 50 · impact 30

Viking Therapeutics VK2735 oral maintenance trial: a large medicinal capsule supporting a heavy stone sphere to represent weight maintenance.

Corporate